ECB-ART-52069
J Immunol Res
2022 Jan 01;2022:5230603. doi: 10.1155/2022/5230603.
Show Gene links
Show Anatomy links
Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease.
Cortes-Serra N
,
Gualdron-Lopez M
,
Pinazo MJ
,
Torrecilhas AC
,
Fernandez-Becerra C
.
???displayArticle.abstract???
Chagas disease, caused by the protozoa parasite Trypanosoma cruzi, is a neglected tropical disease and a major public health problem affecting more than 6 million people worldwide. Many challenges remain in the quest to control Chagas disease: the diagnosis presents several limitations and the two available treatments cause several side effects, presenting limited efficacy during the chronic phase of the disease. In addition, there are no preventive vaccines or biomarkers of therapeutic response or disease outcome. Trypomastigote form and T. cruzi-infected cells release extracellular vesicles (EVs), which are involved in cell-to-cell communication and can modulate the host immune response. Importantly, EVs have been described as promising tools for the development of new therapeutic strategies, such as vaccines, and for the discovery of new biomarkers. Here, we review and discuss the role of EVs secreted during T. cruzi infection and their immunomodulatory properties. Finally, we briefly describe their potential for biomarker discovery and future perspectives as vaccine development tools for Chagas Disease.
???displayArticle.pubmedLink??? 36033396
???displayArticle.link??? J Immunol Res
References [+] :
Aline,
Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection.
2004, Pubmed
Aline, Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. 2004, Pubmed
Alonso-Padilla, Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America. 2019, Pubmed
Antinori, Chagas disease in Europe: A review for the internist in the globalized world. 2017, Pubmed
Aparici-Herraiz, Antigen Discovery in Circulating Extracellular Vesicles From Plasmodium vivax Patients. 2021, Pubmed
Babatunde, Malaria infected red blood cells release small regulatory RNAs through extracellular vesicles. 2018, Pubmed
Bautista-López, Characterization and Diagnostic Application of Trypanosoma cruzi Trypomastigote Excreted-Secreted Antigens Shed in Extracellular Vesicles Released from Infected Mammalian Cells. 2017, Pubmed
Bayer-Santos, Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins. 2013, Pubmed
Beauvillain, Exosomes are an effective vaccine against congenital toxoplasmosis in mice. 2009, Pubmed
Beauvillain, A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice. 2007, Pubmed
Bern, Chagas' Disease. 2015, Pubmed
Caeiro, The protein family TcTASV-C is a novel Trypanosoma cruzi virulence factor secreted in extracellular vesicles by trypomastigotes and highly expressed in bloodstream forms. 2018, Pubmed
Campos, Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases. 2015, Pubmed , Echinobase
Campos, Augmented plasma microparticles during acute Plasmodium vivax infection. 2010, Pubmed
Cestari, Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. 2012, Pubmed
Choudhuri, PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease. 2020, Pubmed
Chowdhury, Gene Expression Profiling and Functional Characterization of Macrophages in Response to Circulatory Microparticles Produced during Trypanosoma cruzi Infection and Chagas Disease. 2017, Pubmed
Coakley, Exosomes and Other Extracellular Vesicles: The New Communicators in Parasite Infections. 2015, Pubmed
Colombo, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. 2014, Pubmed
Cortes-Serra, Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease. 2020, Pubmed
Cortes-Serra, State-of-the-art in host-derived biomarkers of Chagas disease prognosis and early evaluation of anti-Trypanosoma cruzi treatment response. 2020, Pubmed
Coura, Chagas disease: a new worldwide challenge. 2010, Pubmed
Cronemberger-Andrade, Trypanosoma cruzi-Infected Human Macrophages Shed Proinflammatory Extracellular Vesicles That Enhance Host-Cell Invasion via Toll-Like Receptor 2. 2020, Pubmed
De Pablos, The C-terminal region of Trypanosoma cruzi MASPs is antigenic and secreted via exovesicles. 2016, Pubmed
Dekel, 20S proteasomes secreted by the malaria parasite promote its growth. 2021, Pubmed
Dias, The impact of Chagas disease control in Latin America: a review. 2002, Pubmed
Dong, Extracellular vesicles and leishmaniasis: Current knowledge and promising avenues for future development. 2021, Pubmed
Dumonteil, The Case for the Development of a Chagas Disease Vaccine: Why? How? When? 2021, Pubmed
Díaz Lozano, Immune complexes in chronic Chagas disease patients are formed by exovesicles from Trypanosoma cruzi carrying the conserved MASP N-terminal region. 2017, Pubmed
Evans-Osses, Microvesicles released from Giardia intestinalis disturb host-pathogen response in vitro. 2017, Pubmed
Evans-Osses, Exosomes or microvesicles? Two kinds of extracellular vesicles with different routes to modify protozoan-host cell interaction. 2015, Pubmed
Ferreira, TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease. 2019, Pubmed
Gascon, Chagas disease in Spain, the United States and other non-endemic countries. 2010, Pubmed
Gonçalves, Trypanosoma cruzi: shedding of surface antigens as membrane vesicles. 1991, Pubmed
Gualdrón-López, Characterization of Plasmodium vivax Proteins in Plasma-Derived Exosomes From Malaria-Infected Liver-Chimeric Humanized Mice. 2018, Pubmed
Khosravi, Isolation and Functions of Extracellular Vesicles Derived from Parasites: The Promise of a New Era in Immunotherapy, Vaccination, and Diagnosis. 2020, Pubmed
Kim, Exosomes Secreted by Toxoplasma gondii-Infected L6 Cells: Their Effects on Host Cell Proliferation and Cell Cycle Changes. 2016, Pubmed
Lovo-Martins, Extracellular Vesicles Shed By Trypanosoma cruzi Potentiate Infection and Elicit Lipid Body Formation and PGE2 Production in Murine Macrophages. 2018, Pubmed
Madeira, New Biomarker in Chagas Disease: Extracellular Vesicles Isolated from Peripheral Blood in Chronic Chagas Disease Patients Modulate the Human Immune Response. 2021, Pubmed
Maia, Characterization of murine extracellular vesicles and Toxoplasma gondii infection. 2021, Pubmed
Mantel, The role of extracellular vesicles in Plasmodium and other protozoan parasites. 2014, Pubmed
Mantel, Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. 2013, Pubmed
Marcilla, Extracellular vesicles in parasitic diseases. 2014, Pubmed
Marcilla, Extracellular vesicles from parasitic helminths contain specific excretory/secretory proteins and are internalized in intestinal host cells. 2012, Pubmed
Martin-Jaular, Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections. 2011, Pubmed
Martins, Molecular Characterization of a Novel Family of Trypanosoma cruzi Surface Membrane Proteins (TcSMP) Involved in Mammalian Host Cell Invasion. 2015, Pubmed
Martín-Jaular, Spleen-Dependent Immune Protection Elicited by CpG Adjuvanted Reticulocyte-Derived Exosomes from Malaria Infection Is Associated with Changes in T cell Subsets' Distribution. 2016, Pubmed
Mekonnen, Extracellular vesicles from parasitic helminths and their potential utility as vaccines. 2018, Pubmed
Meningher, Schistosomal MicroRNAs Isolated From Extracellular Vesicles in Sera of Infected Patients: A New Tool for Diagnosis and Follow-up of Human Schistosomiasis. 2017, Pubmed
Ming, Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. 1995, Pubmed
Nakayasu, Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi. 2012, Pubmed
Neves, Trypanosoma cruzi-secreted vesicles have acid and alkaline phosphatase activities capable of increasing parasite adhesion and infection. 2014, Pubmed
Nogueira, Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses. 2015, Pubmed , Echinobase
Nowacki, Protein and small non-coding RNA-enriched extracellular vesicles are released by the pathogenic blood fluke Schistosoma mansoni. 2015, Pubmed
Olivier, Leishmania and its exosomal pathway: a novel direction for vaccine development. 2019, Pubmed
Pinazo, The importance of the multidisciplinary approach to deal with the new epidemiological scenario of Chagas disease (global health). 2015, Pubmed
Pope, Toxoplasma gondii infection of fibroblasts causes the production of exosome-like vesicles containing a unique array of mRNA and miRNA transcripts compared to serum starvation. 2013, Pubmed
Properzi, Exosomes: the future of biomarkers in medicine. 2013, Pubmed
Pérez-Molina, Old and new challenges in Chagas disease. 2015, Pubmed
Pérez-Molina, Chagas disease cardiomyopathy treatment remains a challenge - Authors' reply. 2018, Pubmed
Queiroz, Insight into the Exoproteome of the Tissue-Derived Trypomastigote form of Trypanosoma cruzi. 2016, Pubmed
Ramirez, Dynamic flux of microvesicles modulate parasite-host cell interaction of Trypanosoma cruzi in eukaryotic cells. 2017, Pubmed
Regev-Rudzki, Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. 2013, Pubmed
Retana Moreira, Biophysical and Biochemical Comparison of Extracellular Vesicles Produced by Infective and Non-Infective Stages of Trypanosoma cruzi. 2021, Pubmed
Retana Moreira, Extracellular vesicles of Trypanosoma cruzi tissue-culture cell-derived trypomastigotes: Induction of physiological changes in non-parasitized culture cells. 2019, Pubmed
Ribeiro, Proteomic analysis reveals different composition of extracellular vesicles released by two Trypanosoma cruzi strains associated with their distinct interaction with host cells. 2018, Pubmed , Echinobase
Rodríguez-Morales, Experimental Vaccines against Chagas Disease: A Journey through History. 2015, Pubmed
Sahu, Association of TNF level with production of circulating cellular microparticles during clinical manifestation of human cerebral malaria. 2013, Pubmed
Saraiva, Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care. 2021, Pubmed
Serna, A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease. 2014, Pubmed
Szempruch, Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia. 2016, Pubmed
Théry, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. 2018, Pubmed , Echinobase
Toda, Plasma-derived extracellular vesicles from Plasmodium vivax patients signal spleen fibroblasts via NF-kB facilitating parasite cytoadherence. 2020, Pubmed
Torrecilhas, Extracellular Vesicles in Trypanosomatids: Host Cell Communication. 2020, Pubmed
Torrecilhas, Vesicles as carriers of virulence factors in parasitic protozoan diseases. 2012, Pubmed , Echinobase
Trocoli Torrecilhas, Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. 2009, Pubmed
Vasconcelos, Stress Induces Release of Extracellular Vesicles by Trypanosoma cruzi Trypomastigotes. 2021, Pubmed
Vázquez-Chagoyán, Vaccine development against Trypanosoma cruzi and Chagas disease. 2011, Pubmed
Wyllie, Microvesicles released during the interaction between Trypanosoma cruzi TcI and TcII strains and host blood cells inhibit complement system and increase the infectivity of metacyclic forms of host cells in a strain-independent process. 2017, Pubmed
Yáñez-Mó, Biological properties of extracellular vesicles and their physiological functions. 2015, Pubmed
Zhang, Exosomes: biogenesis, biologic function and clinical potential. 2019, Pubmed
Zhou, The function and clinical application of extracellular vesicles in innate immune regulation. 2020, Pubmed
da Costa, Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease. 2021, Pubmed
da Fonseca, Theft and Reception of Host Cell's Sialic Acid: Dynamics of Trypanosoma Cruzi Trans-sialidases and Mucin-Like Molecules on Chagas' Disease Immunomodulation. 2019, Pubmed
da Silveira, Plasma membrane vesicles isolated from epimastigote forms of Trypanosoma cruzi. 1979, Pubmed